title: The management of hydrothorax in continuous ambulatory peritoneal dialysis (CAPD).
abstract: Four patients on continuous ambulatory peritoneal dialysis (CAPD) developed large, symptomatic pleural effusions after commencing peritoneal dialysis. Pleuroperitoneal fistula in each case was diagnosed by the presence of a high glucose content in pleural fluid, with a normal corresponding blood sugar, and was confirmed by isotope or contrast peritoneography. Two patients had their effusions drained percutaneously, and then underwent pleural sclerosis with intracavitary tetracycline. Two patients had a thoracotomy performed, of which no fistula was identified in one case, and the other patient underwent pleurectomy. All four patients successfully recommenced CAPD several weeks after therapy, without recurrence of effusions. We conclude that pleuroperitoneal connections associated with CAPD do not mandate cessation of peritoneal dialysis and conversion to maintenance haemodialysis. Definitive diagnosis requires aspiration of pleural effusions for glucose estimation. Contrast or isotopic peritoneography is helpful in localising the fistula, but in our experience did not alter management. Simple sclerotherapy is effective and avoids the need for a formal thoracotomy.
authors.affiliation: Department of Nephrology, Beaumont Hospital, Dublin, Ireland.
authors.forename: A
authors.initials: A
authors.lastname: Green
authors.forename: M
authors.initials: M
authors.lastname: Logan
authors.forename: W
authors.initials: W
authors.lastname: Medawar
authors.forename: F
authors.initials: F
authors.lastname: McGrath
authors.forename: F
authors.initials: F
authors.lastname: Keeling
authors.forename: M
authors.initials: M
authors.lastname: Carmody
authors.forename: J
authors.initials: J
authors.lastname: Donohoe
mesh_terms: D000368:Aged; D005260:Female; D005402:Fistula / Q000209:etiology / Q000628:therapy; D006801:Humans; D006876:Hydrothorax / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010532:Peritoneal Diseases / Q000209:etiology / Q000628:therapy; D010995:Pleural Diseases / Q000209:etiology / Q000628:therapy; D015911:Sclerotherapy